Cargando…

HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury

BACKGROUND: In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales: Billin, Andrew N., Honeycutt, Samuel E., McDougal, Alan V., Kerr, Jaclyn P., Chen, Zhe, Freudenberg, Johannes M., Rajpal, Deepak K., Luo, Guizhen, Kramer, Henning Fritz, Geske, Robert S., Fang, Frank, Yao, Bert, Clark, Richard V., Lepore, John, Cobitz, Alex, Miller, Ram, Nosaka, Kazunori, Hinken, Aaron C., Russell, Alan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234580/
https://www.ncbi.nlm.nih.gov/pubmed/30424786
http://dx.doi.org/10.1186/s13395-018-0179-5
_version_ 1783370723058778112
author Billin, Andrew N.
Honeycutt, Samuel E.
McDougal, Alan V.
Kerr, Jaclyn P.
Chen, Zhe
Freudenberg, Johannes M.
Rajpal, Deepak K.
Luo, Guizhen
Kramer, Henning Fritz
Geske, Robert S.
Fang, Frank
Yao, Bert
Clark, Richard V.
Lepore, John
Cobitz, Alex
Miller, Ram
Nosaka, Kazunori
Hinken, Aaron C.
Russell, Alan J.
author_facet Billin, Andrew N.
Honeycutt, Samuel E.
McDougal, Alan V.
Kerr, Jaclyn P.
Chen, Zhe
Freudenberg, Johannes M.
Rajpal, Deepak K.
Luo, Guizhen
Kramer, Henning Fritz
Geske, Robert S.
Fang, Frank
Yao, Bert
Clark, Richard V.
Lepore, John
Cobitz, Alex
Miller, Ram
Nosaka, Kazunori
Hinken, Aaron C.
Russell, Alan J.
author_sort Billin, Andrew N.
collection PubMed
description BACKGROUND: In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcription under conditions of low oxygen, and HIF target genes EPO and VEGF have been associated with muscle protection and repair. We tested the importance of HIF activation following skeletal muscle injury, in both a murine model and human volunteers, using prolyl hydroxylase inhibitors that stabilize and activate HIF. METHODS: Using a mouse eccentric limb injury model, we characterized the protective effects of prolyl hydroxylase inhibitor, GSK1120360A. We then extended these studies to examine the impact of EPO modulation and infiltrating immune cell populations on muscle protection. Finally, we extended this study with an experimental medicine approach using eccentric arm exercise in untrained volunteers to measure the muscle-protective effects of a clinical prolyl hydroxylase inhibitor, daprodustat. RESULTS: GSK1120360A dramatically prevented functional deficits and histological damage, while accelerating recovery after eccentric limb injury in mice. Surprisingly, this effect was independent of EPO, but required myeloid HIF1α-mediated iNOS activity. Treatment of healthy human volunteers with high-dose daprodustat reduced accumulation of circulating damage markers following eccentric arm exercise, although we did not observe any diminution of functional deficits with compound treatment. CONCLUSION: The results of these experiments highlight a novel skeletal muscle protective effect of prolyl hydroxylase inhibition via HIF-mediated expression of iNOS in macrophages. Partial recapitulation of these findings in healthy volunteers suggests elements of consistent pharmacology compared to responses in mice although there are clear differences between these two systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13395-018-0179-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6234580
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62345802018-11-23 HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury Billin, Andrew N. Honeycutt, Samuel E. McDougal, Alan V. Kerr, Jaclyn P. Chen, Zhe Freudenberg, Johannes M. Rajpal, Deepak K. Luo, Guizhen Kramer, Henning Fritz Geske, Robert S. Fang, Frank Yao, Bert Clark, Richard V. Lepore, John Cobitz, Alex Miller, Ram Nosaka, Kazunori Hinken, Aaron C. Russell, Alan J. Skelet Muscle Research BACKGROUND: In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcription under conditions of low oxygen, and HIF target genes EPO and VEGF have been associated with muscle protection and repair. We tested the importance of HIF activation following skeletal muscle injury, in both a murine model and human volunteers, using prolyl hydroxylase inhibitors that stabilize and activate HIF. METHODS: Using a mouse eccentric limb injury model, we characterized the protective effects of prolyl hydroxylase inhibitor, GSK1120360A. We then extended these studies to examine the impact of EPO modulation and infiltrating immune cell populations on muscle protection. Finally, we extended this study with an experimental medicine approach using eccentric arm exercise in untrained volunteers to measure the muscle-protective effects of a clinical prolyl hydroxylase inhibitor, daprodustat. RESULTS: GSK1120360A dramatically prevented functional deficits and histological damage, while accelerating recovery after eccentric limb injury in mice. Surprisingly, this effect was independent of EPO, but required myeloid HIF1α-mediated iNOS activity. Treatment of healthy human volunteers with high-dose daprodustat reduced accumulation of circulating damage markers following eccentric arm exercise, although we did not observe any diminution of functional deficits with compound treatment. CONCLUSION: The results of these experiments highlight a novel skeletal muscle protective effect of prolyl hydroxylase inhibition via HIF-mediated expression of iNOS in macrophages. Partial recapitulation of these findings in healthy volunteers suggests elements of consistent pharmacology compared to responses in mice although there are clear differences between these two systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13395-018-0179-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-13 /pmc/articles/PMC6234580/ /pubmed/30424786 http://dx.doi.org/10.1186/s13395-018-0179-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Billin, Andrew N.
Honeycutt, Samuel E.
McDougal, Alan V.
Kerr, Jaclyn P.
Chen, Zhe
Freudenberg, Johannes M.
Rajpal, Deepak K.
Luo, Guizhen
Kramer, Henning Fritz
Geske, Robert S.
Fang, Frank
Yao, Bert
Clark, Richard V.
Lepore, John
Cobitz, Alex
Miller, Ram
Nosaka, Kazunori
Hinken, Aaron C.
Russell, Alan J.
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
title HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
title_full HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
title_fullStr HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
title_full_unstemmed HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
title_short HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
title_sort hif prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234580/
https://www.ncbi.nlm.nih.gov/pubmed/30424786
http://dx.doi.org/10.1186/s13395-018-0179-5
work_keys_str_mv AT billinandrewn hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT honeycuttsamuele hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT mcdougalalanv hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT kerrjaclynp hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT chenzhe hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT freudenbergjohannesm hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT rajpaldeepakk hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT luoguizhen hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT kramerhenningfritz hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT geskeroberts hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT fangfrank hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT yaobert hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT clarkrichardv hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT leporejohn hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT cobitzalex hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT millerram hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT nosakakazunori hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT hinkenaaronc hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury
AT russellalanj hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury